NIAMS to Fund Small Business Grants for Multiplex Assay Projects | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Arthritis and Musculoskeletal and Skin Diseases aims to fund small businesses developing new multiplex diagnostic technologies that target biomarkers for a range of diseases.

NIAMS plans to provide Small Business Innovation Research grants of $150,000 for phase I projects and $1 million for phase II efforts to businesses developing multiplex tools for measuring multiple protein, DNA, or RNA-based biomarkers that can be detected in small volumes of fluid or biopsies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.